Imugene has “enviable cash runway” says Roth Capital Partners, placing 'buy' recommendation on cancer therapy biotech
Imugene Ltd (ASX:IMU, OTC:IUGNF)’s recent clinical activities – including brokering partnerships and securing patents – along with a well-funded cash position, have prompted Roth Capital Partners to place a 'buy' recommendation on the clinical-stage oncology company.
The company started the year with A$118.4 million, enough to fund operations for almost four years, and an “enviable cash runway”. It has also accomplished a great deal in the clinical space over the eight months to the first half of this financial year.
Price target maintained
“Our 12-month price target of A$0.71 is based on a DCF analysis using a 15% discount rate that is applied to all cash flows and the terminal value, which is based on a 6x multiple of our projected FY2031 operating income of about A$1.47 billion,” said the Roth Capital Partners report.
“We arrive at this valuation by projecting future revenue from CHECKvacc in TNBC, HER-Vaxx in advanced HER2+ gastric cancer, and PD1-Vaxx in NSCLC.
"Commercial success outside these financially modelled programs would serve as potential upside to our valuation."
IMUGENE CHART. TA only, page-12843
-
- There are more pages in this discussion • 20,647 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
|
|||||
Last
5.9¢ |
Change
0.005(9.26%) |
Mkt cap ! $433.6M |
Open | High | Low | Value | Volume |
5.5¢ | 5.9¢ | 5.4¢ | $1.489M | 25.99M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 35252 | 5.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.0¢ | 1753430 | 24 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 717241 | 0.058 |
8 | 1860543 | 0.057 |
3 | 1067860 | 0.056 |
20 | 2643992 | 0.055 |
6 | 1127777 | 0.054 |
Price($) | Vol. | No. |
---|---|---|
0.060 | 1095176 | 20 |
0.061 | 520305 | 5 |
0.062 | 290000 | 4 |
0.063 | 100000 | 1 |
0.064 | 217000 | 3 |
Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |